CAPTRUST Financial Advisors
AERI

CAPTRUST Financial Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-436
Closed -$3K – 4557
2022
Q2 		$3K Sell
436
-67
-13% -$472 ﹤0.01% 4385
2022
Q1 		$5K Buy
+503
New +$3.88K ﹤0.01% 4199
2021
Q4 		– Sell
-376
Closed -$4K – 5028
2021
Q3 		$4K Hold
376
– – ﹤0.01% 4076
2021
Q2 		$6K Buy
+376
New +$6.45K ﹤0.01% 3816

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAPTRUST Financial Advisors's AERI Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 436 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in AERI in Q2 2021 and held it in 4 quarters. The position peaked at $6K in Q2 2021. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 436 Aerie Pharmaceuticals shares in Q3 2022, an estimated $3K.
  • CAPTRUST Financial Advisors first reported a position in Aerie Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Aerie Pharmaceuticals position peaked at $6K in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.